Finance

Lists
RMDEF:OTCMKTS
Remedy Entertainment Oyj
$15.50
0.00%
(0.00) 1D
Jul 7, 9:30:08 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RMDEF...
Mkt. cap
231.08M
Avg. vol.
11.00
Volume
0.00
52-wk high
$16.76
52-wk low
$15.12
Beta
0.10
Shares outstanding
13.64M
No. of employees
379
Mkt. cap
231.08M
Avg. vol.
11.00
Volume
0.00
52-wk high
$16.76
52-wk low
$15.12
Beta
0.10
Shares outstanding
13.64M
No. of employees
379
Profile
Remedy Entertainment Oyj, trading internationally as Remedy Entertainment Plc, is a Finnish video game developer based in Espoo. Notable games the studio has developed include the first two entries in the Max Payne franchise, Alan Wake, Quantum Break, and Control. Sam Lake, Remedy's creative director, has represented the company on numerous occasions. Founded in August 1995 by members of demoscene group Future Crew, Remedy Entertainment created its first game, Death Rally, in a team member's basement. Apogee Software served as the game's publisher, and continued to be involved in the production of its next title, Max Payne, which received critical acclaim upon release. The game was followed by a sequel, Max Payne 2: The Fall of Max Payne, released by Rockstar Games. After spending seven years working on the Max Payne franchise, the developer decided to create a new intellectual property called Alan Wake. This title was once suspected to be vaporware because of the length of time it took to produce and release. It gained a cult following when it was released in 2010, by Microsoft Game Studios, though at the time its sales were not enough to justify the production of a sequel. Wikipedia
About Remedy Entertainment Oyj
CEO-
Employees379
FoundedAug 18, 1995
Headquarters-
Sector-
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
12.16M
17.04M
13.14M
10.16M
Cost of goods sold
2.40M
4.23M
907.00K
1.15M
Cost of revenue
2.40M
4.23M
907.00K
1.15M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.84M
9.52M
6.34M
6.74M
Operating expense
26.18M
-2.83M
11.20M
12.95M
Total operating expenses
28.58M
1.40M
12.11M
14.10M
Operating income
-16.42M
15.64M
1.03M
-3.94M
Other non operating income
-
621.00K
-
-1.00K
EBT including unusual items
-16.70M
453.00K
752.00K
-3.91M
EBT excluding unusual items
-16.70M
15.37M
752.00K
-3.91M
Income tax expense
-3.24M
52.00K
276.00K
-668.00K
Effective tax rate
19.42%
11.48%
36.70%
17.08%
Other operating expenses
3.23M
-565.00K
2.96M
4.66M
Net income
-13.45M
401.00K
476.00K
-3.24M
Net profit margin
-110.68%
2.35%
3.62%
-31.94%
Earnings per share
-0.99
0.03
0.04
-0.24
Interest and investment income
271.00K
40.00K
13.00K
488.00K
Interest expense
-543.00K
-703.00K
-290.00K
-455.00K
Net interest expenses
-272.00K
-663.00K
-277.00K
33.00K
Depreciation and amortization charges
17.11M
-11.78M
1.90M
1.55M
EBITDA
-15.83M
16.15M
1.51M
-3.46M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps